Lubrizol LifeSciences announces new compounding capabilities

Solutions provider for medical and pharmaceutical manufacturers, Lubrizol Corporation’s LifeSciences (LLS) has announced the addition of compounding capabilities for its Pellethane and Isoplast products for medical device customers.

The news comes from the MD&M West show in Anaheim, California, where LLS is exhibiting its total solutions capabilities. 

The new compounding capabilities allows LLS to provide colour matching, radiopacity and custom compound development services. It is made possible through a partnership with custom medical plastics compounder, Compounding Solutions.

The new service also allows LLS to provide custom colour matching for brand recognition, safe identification and aesthetics in medical device applications.

Along with colour matching, LLS also offers radiopaque materials for X-ray identification and proper device positioning; critical for patient safety and comfort. Pellethane and Isoplast compounds with barium sulfate and tungsten are now both available from LLS.

The company has also announced a significant investment to expand its global development and manufacturing facilities. LLS state that the investment will expand multiple facilities and increase Lubrizol LifeSciences` in-house engineering capacity for both silicone and thermoplastic products.

Robert Miller, general manager, Lubrizol LifeSciences said: "When customers partner with Lubrizol LifeSciences, they benefit from working with us at every stage in their development process. With a long history of polymer expertise and recent investments, Lubrizol LifeSciences is positioned to offer full-service development for next generation medical and drug-eluting device innovations."